Bewersdorf JP, Patel KK, Shallis RM, Podoltsev NA, et al. Cost-effectiveness of adding quizartinib to induction chemotherapy for patients with FLT3-mutant acute myeloid leukemia. Leuk Lymphoma 2024 Apr 22:1-9. doi: 10.1080/10428194.2024.2344052.
PMID: 38648559